In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 36 for your search:
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  oral complications
Country:  U.S.A.
Trial Type:  Supportive care
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AAO-101, NCT00466388

2.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20040212, UCLA-0412042-01, AMGEN-20040212, NCT00109031

3.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0920, CDR0000651536, NCI-2011-00878, NCT00956007

4.

Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: 2010-0547 MDA, MDA-04-01, CDR0000674208, 2010-0547, NCT01141231

5.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCCTG-N09C6, NCI-2011-02049, CDR0000675520, N09C6, NCT01156142

6.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2010-0584, NCI-2011-00306, R01CA148707-01A1, NCT01266044

7.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-034, NCT01355926

8.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000727295, NCCTG-N11C5, N11C5, NCT01545687

9.

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 603EUSA03, NCT00901732

10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2010-0506, NCI-2012-01906, NCT01237951

11.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: BA2009/28/01, NCT01385748

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 12 to 99
Sponsor: NCI
Protocol IDs: 120068, 12-C-0068, NCT01557517

13.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: WVU041011, NCT01566448

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: OSU-11055, NCI-2012-00459, NCT01653106

15.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: D1022, NCT01653327

16.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 andover
Sponsor: Other
Protocol IDs: IRB00008071, CPC-12095-L, NCI-2012-02780, NCT01748942

17.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 89
Sponsor: NCI, Other
Protocol IDs: 101529, 1R21CA158530-01A1, NCT01898091

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CC# 13202, NCT01930435

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CCCWFU 98513, NCI-2013-01741, P30CA012197, NCT01941810

20.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: IDR-OM-01, NCT02013050

21.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 to 95
Sponsor: Other
Protocol IDs: IRB00065591, NCT02075112

22.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 20 to 85
Sponsor: Other
Protocol IDs: 12.0220, NCT01668849

23.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GT-001, NCT01921426

24.

Phase: No phase specified
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 186-03, ETH136-03D, NCT00206752

25.

Phase: No phase specified
Type: Natural history/Epidemiology, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: No. 200509024, NCT00336609
1   
New Search